New compound shows promise in Alzheimer’s preclinical models

Aging News

New compound shows promise in Alzheimer’s preclinical models
Alzheimer's DiseaseBrainCompound
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 44 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 59%
  • Publisher: 71%

A multidisciplinary team of scientists led by Kurt Brunden, Ph.D., at the University of Pennsylvania Perelman School of Medicine, and Carlo Ballatore, Ph.D., at University of California San Diego, has been awarded a $6.

University of PennsylvaniaAug 21 2024 9 million grant from the National Institute on Aging to prepare a potential disease-modifying Alzheimer's treatment for future clinical trials. In a recently published study about the new compound, called CNDR-51997, the team found it was effective in restoring brain health in mouse models of Alzheimer's disease. CNDR-51997 was identified through a joint drug discovery program at Penn and UC San Diego that was supported by grants from the NIA.

Alzheimer's disease is characterized by abnormal deposits of two types of protein in the brain: amyloid beta and tau. The only currently available disease-modifying treatments for Alzheimer's, lecanemab and donanemab , target Aβ deposits in the brain. Notably, there are currently no approved therapies that target pathological tau. In mice, the researchers found that CNDR-51997 was able to reduce both Aβ plaques and tau pathology in the brain.

"Our findings that CNDR-51997 reduces both Aβ plaques and tau inclusions in mouse models suggest that the compound holds considerable promise for Alzheimer's disease. However, there is also a great unmet need for disease-modifying drugs for the other tauopathies," said Brunden, a research professor and director of drug discovery at Penn's Center for Neurodegenerative Disease Research.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Alzheimer's Disease Brain Compound Drug Discovery Medicine Pathology Ph Preclinical Protein Research Tau Protein

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Louise Thompson thought she had Alzheimers before amid 'petrifying' symptomsLouise Thompson thought she had Alzheimers before amid 'petrifying' symptomsMade in Chelsea star Louise Thompson has opened up about her health diagnosis, while sharing photos of her holiday outfits in Ibiza with partner Ryan Libbey
Read more »

Huge student accommodation in city centre ready for new academic yearHuge student accommodation in city centre ready for new academic yearIt will open to both University of Nottingham and Nottingham Trent University students in September
Read more »

Clearing: everything you need to know about applying to Ulster UniversityClearing: everything you need to know about applying to Ulster UniversityUlster University is currently rated the 1 university in the UK on Student Crowd
Read more »

Clearing: everything you need to know about applying to Ulster UniversityClearing: everything you need to know about applying to Ulster UniversityUlster University is currently rated the 1 university in the UK on Student Crowd
Read more »

Plans for new Glasgow University Campus with hotel, student flats and nurseryPlans for new Glasgow University Campus with hotel, student flats and nurseryIf the plans are accepted, the new keystone building will be part of the extension to the University of Glasgow’s Gilmorehill Campus on the former Western Infirmary site.
Read more »

Plans for new Glasgow University campus include nursery and hotelsPlans for new Glasgow University campus include nursery and hotelsThe proposed development also includes teaching, research, sports and recreation facilities alongside housing.
Read more »



Render Time: 2025-02-13 19:00:52